Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single‐center retrospective study
Cancer Medicine · 2024
DOI: 10.1002/cam4.7248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Jian Pang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Breast Neoplasms, Obesity, Body Mass Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Sentinel lymph node biopsy (SLNB) is a common choice for axillary surgery in patients with early‐stage breast cancer (BC) who have clinically negative lymph nodes. Most research indicates that obesity is a prognostic factor for BC patients, but studies assessing its association with the rate of positive sentinel lymph nodes (SLN) and the prognosis of patients with early BC undergoing SLNB are limited.
Methods
Between 2013 and 2016, 7062 early‐stage BC patients from the Shanghai Cancer Center of Fudan University were included. Based on the Chinese Body Mass Index (BMI) classification standards, the patients were divided into three groups as follows: normal weight, overweight, and obese. Propensity score matching analysis was used to balance the baseline characteristics of the participants. Logistic regression analysis was used to determine the association between obesity and positive SLN rate. Cox regression analysis was used to investigate whether obesity was an independent prognostic factor for early‐stage BC patients who had undergone SLNB.
Results
No significant association was observed between obesity and positive SLN rate in early‐stage BC patients who had undergone SLNB. However, multivariate analysis revealed that compared to patients with normal BMI, the overall survival (hazard ratio (HR) 2.240, 95% confidence interval (CI) 1.27–3.95, p = 0.005) and disease‐free survival (HR 1.750, 95% CI 1.16–2.62, p = 0.007) were poorer in patients with high BMI.
Conclusion
Obesity is an independent prognostic factor for early‐stage BC patients who undergo SLNB; however, it does not affect the positive SLN rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Breast Surgery, Shanghai Cancer Center, Fudan University, Shanghai, China.
- Department of Operating Room, Changde First People's Hospital, Changde, China.
- Collaborative Innovation Center for Cancer Medicine, Shanghai, China.
ORCID-Profile: Jian Pang, Lun Li, Jingyan Xue, Jiong Wu
Zitieren
APA
Pang, J., Li, L., Yin, N., Dai, M., Zheng, S., Chen, M., Xue, J., & Wu, J. (2024). Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single‐center retrospective study. Cancer Medicine. https://doi.org/10.1002/cam4.7248
Vancouver
Pang J, Li L, Yin N, Dai M, Zheng S, Chen M, et al. Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single‐center retrospective study. Cancer Medicine. 2024. doi:10.1002/cam4.7248
BibTeX
@article{Pang2024,
author = {Pang, Jian and Li, Lun and Yin, Nana and Dai, Mei and Zheng, Shuyue and Chen, Ming and Xue, Jingyan and Wu, Jiong},
title = {Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single‐center retrospective study},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7248}
}
EUVIMED